Payment overview · 2025
General Payments
$16.62
1 reported records · 1 companies
Healthcare provider profile · identity verified
Acquanetta Frazier, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology · GREENBELT, MD · NPI 1043380140
Verified facts
What the public records show
CMS Open Payments records show Acquanetta Frazier, M.D. received $16.62 in general payments during 2025 across 1 reported records.
Novo Nordisk Inc accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $16.62 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $16.62 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Wegovy Normalized: wegovy |
Drug | Novo Nordisk Inc | $16.62 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 894 | 81 |
| Amlodipine Besylate | Amlodipine Besylate | 704 | 45 |
| Eliquis | Apixaban | 585 | 33 |
| Lisinopril | Lisinopril | 499 | 26 |
| Gabapentin | Gabapentin | 322 | 20 |
| Levothyroxine Sodium | Levothyroxine Sodium | 299 | 16 |
| Losartan Potassium | Losartan Potassium | 282 | 24 |
| Donepezil Hcl | Donepezil Hcl | 279 | 15 |
| Furosemide | Furosemide | 261 | 26 |
| Metformin Hcl | Metformin Hcl | 252 | 21 |
| Pantoprazole Sodium | Pantoprazole Sodium | 250 | 22 |
| Mirtazapine | Mirtazapine | 232 | 29 |
| Clopidogrel | Clopidogrel Bisulfate | 227 | 22 |
| Metoprolol Tartrate | Metoprolol Tartrate | 190 | 21 |
| Metoprolol Succinate | Metoprolol Succinate | 183 | 16 |
| Tamsulosin Hcl | Tamsulosin Hcl | 176 | 15 |
| Potassium Chloride | Potassium Chloride | 170 | 12 |
| Famotidine | Famotidine | 164 | 21 |
| Hydralazine Hcl | Hydralazine Hcl | 164 | 13 |
| Trazodone Hcl | Trazodone Hcl | 162 | 13 |
| Hydrochlorothiazide | Hydrochlorothiazide | 155 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 148 | 17 |
| Carvedilol | Carvedilol | 128 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 127 | suppressed |
| Finasteride | Finasteride | 116 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 105 | suppressed |
| Latanoprost | Latanoprost | 102 | 21 |
| Sertraline Hcl | Sertraline Hcl | 99 | suppressed |
| Sucralfate | Sucralfate | 95 | suppressed |
| Omeprazole | Omeprazole | 94 | 20 |
| Jardiance | Empagliflozin | 92 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 84 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 83 | suppressed |
| Lamotrigine | Lamotrigine | 83 | suppressed |
| Levetiracetam | Levetiracetam | 79 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 74 | suppressed |
| Simvastatin | Simvastatin | 73 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 71 | suppressed |
| Risperidone | Risperidone | 70 | suppressed |
| Memantine Hcl | Memantine Hcl | 69 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 67 | 18 |
| Calcitriol | Calcitriol | 60 | suppressed |
| Entresto | Sacubitril/Valsartan | 57 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 57 | suppressed |
| Lactulose | Lactulose | 54 | 24 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 53 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 52 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 52 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 51 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 51 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 48 | suppressed |
| Valproic Acid | Valproic Acid | 48 | suppressed |
| Enulose | Lactulose | 47 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 44 | suppressed |
| Clozapine | Clozapine | 42 | suppressed |
| Torsemide | Torsemide | 42 | suppressed |
| Tivicay | Dolutegravir Sodium | 41 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 38 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 37 | suppressed |
| Chlorpromazine Hcl | Chlorpromazine Hcl | 37 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 36 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 35 | suppressed |
| Ketoconazole | Ketoconazole | 33 | 11 |
| Baclofen | Baclofen | 32 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 32 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 29 | suppressed |
| Lorazepam | Lorazepam | 29 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 28 | suppressed |
| Aptiom | Eslicarbazepine Acetate | 27 | suppressed |
| Chlorthalidone | Chlorthalidone | 27 | suppressed |
| Januvia | Sitagliptin Phosphate | 27 | suppressed |
| Westab Plus | Pnv,calcium 72/Iron/Folic Acid | 27 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 26 | suppressed |
| Cinacalcet Hcl | Cinacalcet Hcl | 25 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 25 | suppressed |
| Humalog | Insulin Lispro | 25 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 25 | suppressed |
| Allopurinol | Allopurinol | 24 | suppressed |
| Ammonium Lactate | Ammonium Lactate | 24 | suppressed |
| Clotrimazole | Clotrimazole | 24 | suppressed |
| Myrbetriq | Mirabegron | 24 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 23 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 23 | suppressed |
| Haloperidol | Haloperidol | 22 | suppressed |
| Xarelto | Rivaroxaban | 22 | suppressed |
| Xifaxan | Rifaximin | 22 | suppressed |
| Clonazepam | Clonazepam | 21 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 20 | suppressed |
| Bumetanide | Bumetanide | 19 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 19 | suppressed |
| Nifedipine Er | Nifedipine | 19 | suppressed |
| Prenatal Vitamin Plus Low Iron | Pnv,calcium 72/Iron/Folic Acid | 19 | suppressed |
| Risperdal Consta | Risperidone Microspheres | 19 | suppressed |
| Spironolactone | Spironolactone | 19 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 17 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 17 | suppressed |
| Digoxin | Digoxin | 16 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 16 | suppressed |
| Nystatin | Nystatin | 16 | suppressed |
| Phenobarbital | Phenobarbital | 16 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 15 | suppressed |
| Amoxicillin | Amoxicillin | 15 | 11 |
| Aripiprazole | Aripiprazole | 15 | suppressed |
| Biktarvy | Bictegrav/Emtricit/Tenofov Ala | 15 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 15 | suppressed |
| Gavilyte-G | Peg3350/Sod Sulf,bicarb,cl/Kcl | 15 | 13 |
| Guanfacine Hcl | Guanfacine Hcl | 15 | suppressed |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 15 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 15 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 14 | 11 |
| Cholestyramine | Cholestyramine (With Sugar) | 14 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 14 | suppressed |
| Ibuprofen | Ibuprofen | 14 | 11 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 14 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 14 | suppressed |
| Exelon | Rivastigmine | 13 | suppressed |
| Ranolazine Er | Ranolazine | 13 | suppressed |
| Synthroid | Levothyroxine Sodium | 13 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 13 | suppressed |
| Anastrozole | Anastrozole | 12 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 12 | suppressed |
| Gemfibrozil | Gemfibrozil | 12 | suppressed |
| Irbesartan | Irbesartan | 12 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 12 | suppressed |
| Lithium Carbonate | Lithium Carbonate | 12 | suppressed |
| Meloxicam | Meloxicam | 12 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 12 | suppressed |
| Peg-3350 And Electrolytes | Peg3350/Sod Sulf,bicarb,cl/Kcl | 12 | suppressed |
| Theophylline Er | Theophylline Anhydrous | 12 | suppressed |
| Zonisamide | Zonisamide | 12 | suppressed |
| Anagrelide Hcl | Anagrelide Hcl | 11 | suppressed |
| Colchicine | Colchicine | 11 | suppressed |
| Levemir | Insulin Detemir | 11 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 11 | suppressed |
| Scopolamine | Scopolamine | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $16.62 · 1 records | Novo Nordisk Inc | Wegovy | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error